Since 1934, the Jewish General Hospital (JGH) has been providing cutting edge treatment and compassionate care to patients from diverse religious and cultural backgrounds in Montreal, throughout Quebec and beyond. It is one of the province’s largest and busiest acute-care hospitals.
The Radiation Oncology Division, as an integral part of the Jewish General Hospital’s Segal Cancer Center, is a state-of-art facility, which provides patients with the most comprehensive approach to care, combining cancer prevention, diagnosis, treatment, psychosocial support, nutritional support and clinical and fundamental research in cancer.
The JGH Division of Radiation Oncology has a staff of over 70 cancer-care professionals, including radiation oncologists, technologists, nurses, medical physicists and an engineer. Academic and clinical research also plays a major role in the division. The Brachytherapy suite has an integrated CT-simulator and represents a unique image guided brachytherapy (IGBT) suite in Canada. This exclusive imaging modality has allowed for significantly improved and convenient brachytherapy procedures to patients. They are world leaders in the field of neoadjuvant high-dose-rate endorectal brachytherapy.
The members of the brachytherapy staff are internationally renowned researchers and presenters at international meetings and conferences. In September 2012 a very successful two-day educational workshop, entitled ‘Pre-operative endocavitary HDR brachytherapy for locally advanced rectal cancer’, was organized together with Nucletron. An integrated multidisciplinary overview of the rationale, method and practice of endocavitary brachytherapy for locally advanced rectal cancer was provided in an open and interactive setting.